Comparison of Neoadjuvant Chemotherapy, Chemoimmunotherapy, and Upfront Radical Cystectomy in High-Risk Bladder Cancer: A Single-Center Retrospective Study
Oncology Research · 2026
DOI: 10.32604/or.2026.083704 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Oncology Research, 2026. Verfasst von Shaohua Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Guangxi Medical University Cancer Hospital, Nanning, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Neoadjuvant Therapy, Cystectomy, Antineoplastic Combined Chemotherapy Protocols. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Guangxi Medical University Cancer Hospital, Nanning, China.
- Department of Urology, Wuzhou Workers' Hospital, Wuzhou, China.
Zitieren
APA
Chen, S., Gan, X., Lv, P., Meng, Q., Lin, X., & Zhang, Q. (2026). Comparison of Neoadjuvant Chemotherapy, Chemoimmunotherapy, and Upfront Radical Cystectomy in High-Risk Bladder Cancer: A Single-Center Retrospective Study. Oncology Research. https://doi.org/10.32604/or.2026.083704
Vancouver
Chen S, Gan X, Lv P, Meng Q, Lin X, Zhang Q. Comparison of Neoadjuvant Chemotherapy, Chemoimmunotherapy, and Upfront Radical Cystectomy in High-Risk Bladder Cancer: A Single-Center Retrospective Study. Oncology Research. 2026. doi:10.32604/or.2026.083704
BibTeX
@article{Chen2026,
author = {Chen, Shaohua and Gan, Xiao and Lv, Ping and Meng, Qinggui and Lin, Xiaocao and Zhang, Qingyun},
title = {Comparison of Neoadjuvant Chemotherapy, Chemoimmunotherapy, and Upfront Radical Cystectomy in High-Risk Bladder Cancer: A Single-Center Retrospective Study},
journal = {Oncology Research},
year = {2026},
doi = {10.32604/or.2026.083704}
}
EUVIMED